TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  The Motley Fool

Why Bio-Rad Laboratories Stock Slipped by More Than 3% on Thursday

The Motley Fool Logo The Motley Fool By Eric Volkman
Why Bio-Rad Laboratories Stock Slipped by More Than 3% on Thursday

Bio-Rad Laboratories reported Q3 earnings with modest revenue growth of 0.5% and beat analyst estimates, but investors reacted negatively due to low growth rates and challenges in biotech funding and academic research.

Insights
BIO   negative

Stock dropped over 3% despite beating earnings estimates due to low revenue growth (0.5%), flat future guidance, and ongoing challenges in biotech funding and academic research